» Factor VII Deficient Plasma Immunodepleted

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR VII

Factor VII Deficient Plasma Immunodepleted

Lyophilized plasmas

Plasma deficient for factor VII assay.

Factor VII Deficient Plasma is lyophilized and immuno-depleted human plasma with coagulant activity < 1% for FVII.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5144015
Presentation	Vial
Format	5 x 1.0 mL
Number of assays	100
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
4-5144015	Vial	5 x 1.0 mL	100

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VII (FVII) is a glycoprotein synthesized by the liver, zymogen of a serine protease. It is a vitamin K dependent factor belonging to the prothrombin complex. Its half-life is 4 to 6 hours and it is the only coagulation factor present in trace amounts in its active form.
When tissue factor appears on the endothelial surface, activated FVII associates with it initiating the extrinsic pathway for coagulation. This complex (FT-FVIIa) will activate the FX in FXa and the FIX in FIXa.

- Deficient plasma of human origin, stabilized and lyophilized with an activity < 1% of the corresponding coagulation factor.
- All other coagulation factors have normal values.
- Deficient plasma obtained by immunoadsorption.
- Plasma, deficient in FVII, is used for the determination of FVII by the one-step method based on prothrombin time.

Deficient plasma can be aliquoted and frozen for 1 month at -20 °C after reconstitution.

- 5 vials x 1 mL lyophilized plasma

Coagulation Control A
Coagulation Control N
Coagulation Reference

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR VII